NCT00907660

Brief Summary

We hypothesize that individuals provided with 1 meal per day of portion-controlled foods (shakes and prepared entrees) will lose as much weight as individuals provided with 2 meals per day of portion-controlled foods. The study is designed to assess whether equal weight loss can be achieved at a lower cost to the health care system (or health care payer), with patients contributing some of the cost of their own treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2 obesity

Timeline
Completed

Started May 2009

Shorter than P25 for phase_2 obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 20, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 22, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

January 30, 2020

Status Verified

January 1, 2020

Enrollment Period

10 months

First QC Date

May 20, 2009

Last Update Submit

January 28, 2020

Conditions

Keywords

ObesityWeight lossMeal replacementsHealth services research

Outcome Measures

Primary Outcomes (1)

  • Weight change

    14 weeks

Secondary Outcomes (4)

  • Health-related quality of life

    14 weeks

  • Blood pressure

    14 weeks

  • Waist circumference

    14 weeks

  • Body mass index

    14 weeks

Study Arms (2)

Full Dose

ACTIVE COMPARATOR

Provision of 8 weight loss counseling sessions, calorie guide, pedometer, meal plan, and 2 meals per day of portion-controlled foods (shakes and entrees)

Behavioral: Weight loss counselingDietary Supplement: Portion-Controlled Foods

Half dose

EXPERIMENTAL

Provision of 8 weight loss counseling sessions, calorie guide, pedometer, meal plan, and 1 meal per day of portion-controlled foods (shakes and entrees)

Behavioral: Weight loss counselingDietary Supplement: Portion-Controlled Foods

Interventions

Monitoring of weight; review of food and physical activity records; counseling to reduce calorie intake by 500-1000 calories per day

Also known as: Dietary counseling, Behavior modification, Diet and exercise
Full DoseHalf dose
Portion-Controlled FoodsDIETARY_SUPPLEMENT

Consumption of shakes, meal bars, and prepared entrees for 2 out of 3 meals per day during the 14 weeks of the study. "Full dose" patients are provided with both meals by the study; "half dose" patients are provided with one out of two meals by the study.

Also known as: Meal replacements
Full DoseHalf dose

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients from the University Medicine Denver, University Medicine Anschutz, and A.F. Williams clinics meeting the following criteria
  • Age 18 or older
  • Able to keep a food record for 3 days prior to study entry
  • Able to give informed consent
  • Willing to accept randomization to either treatment condition, to attend all sessions, and to complete study-related assessments
  • Body mass index (BMI) ≥ 30 kg/m2 and \< 50 kg/m2
  • Elevated waist circumference (≥ 88 cm for women, ≥ 102 cm for men) + any one of the following:
  • Glucose intolerance (fasting glucose ≥ 100 or non-fasting glucose ≥ 140, including type 2 diabetes); individuals taking medications for diabetes qualify automatically
  • Elevated blood pressure (≥130/85), including hypertension (≥140/90); individuals taking anti-hypertensive medication qualify automatically
  • Hypertriglyceridemia (TG ≥ 150); individuals taking lipid-lowering medications qualify automatically
  • Decreased high-density lipoprotein (HDL) cholesterol (\< 40 for men, \< 50 for women)
  • Obstructive sleep apnea

You may not qualify if:

  • Medical conditions in which significant weight loss is normally contraindicated (e.g. pregnancy, congestive heart failure requiring diuretics, poorly controlled diabetes, Stage 4 or 5 chronic kidney disease, clinically evident cirrhosis, other severe internal organ disease); exceptions may be made if a referring physician documents that it is safe and appropriate for the individual to lose weight
  • Treated for cancer within the past 5 years, except for basal cell or squamous cell skin cancer; exceptions may be made with written permission from a physician
  • Weight gain or loss of ≥5% of weight in the past 6 months; patients who have not been weight stable may be re-screened in 3 months
  • Concurrent use of corticosteroids or second-generation antipsychotic medications (exceptions may be made for individuals using these medications who have been weight stable for 6 months)
  • Psychiatric diagnoses likely to affect adherence to a research study protocol (e.g., poorly controlled schizophrenia, active substance abuse)
  • Prior or planned bariatric surgery
  • Participation in an organized weight loss program (e.g., Weight Watchers) at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Human Nutrition

Denver, Colorado, 80220, United States

Location

MeSH Terms

Conditions

ObesityWeight Loss

Interventions

Nutrition AssessmentBehavior TherapyDietExercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthPsychotherapyBehavioral Disciplines and ActivitiesNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Adam G Tsai, MD, MSCE

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2009

First Posted

May 22, 2009

Study Start

May 1, 2009

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

January 30, 2020

Record last verified: 2020-01

Locations